-

PROMETRIKA Presents Exploring the Impact of Decentralized Clinical Trials – A Live Webcast

Thursday, October 13, 2022, 6:00 -7:00 PM EDT; Cambridge, MA, USA

A look at the benefits and challenges of decentralized clinical trials and the implications for their long-term adoption

original (Graphic: Business Wire)

(Graphic: Business Wire)

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Join PROMETRIKA and guest Ken Getz, MBA, Executive Director of the Tufts Center for the Study of Drug Development, to explore the ongoing experience with decentralized clinical trials (DCTs). Mr. Getz and Chelsey Ryan, PMP, Director, Clinical Operations and Pharmacovigilance at PROMETRIKA, will review data on DCT use and discuss the types of studies most suited for virtual and remote support. Participants in the live webcast will have the opportunity to discuss with Mr. Getz how to advance DCTs in clinical research.

Mr. Getz has enjoyed a 30-year career of providing research and information to clinical trial professionals in the drive to understand and improve clinical research. An internationally recognized expert on clinical trial management practices and trends, Mr. Getz’s studies on protocol design complexity, clinical research efficiency and effectiveness, and the global outsourcing landscape have contributed to an industry-wide understanding of these critical markets. His current research aims to inform the adoption of decentralized clinical trials.

Ms. Ryan’s extensive 12-year background in leading global clinical research projects has given her the knowledge and insight to translate the many needs of trial stakeholders into unified goals. As the industry embraces decentralization, Ms. Ryan continues to examine the best application of DCT methods to optimize each clinical trial.

“We have gained first-hand experience during the pandemic with, and we’re learning much more about how to optimize the use of, decentralized clinical trial solutions. I’m very excited to be sharing Tufts CSDD data to inform best DCT use practices .”

Ken Getz, MBA
Executive Director and Research Professor
Tufts CSDD

“ We are thrilled to have Ken Getz speak about his in-depth research on decentralized trials. We hope you will join us! The evening promises a robust discussion on the future of clinical research and the role DCTs will play.”

Miganush Stepanians, PhD
Founder, President, and CEO
PROMETRIKA, LLC

Link to Register to the Live Webcast: https://pages.services/events.prometrika.com/Live-Webcast-dct-event-page/

Contacts

For further information please contact
Kathy Zheng
kzheng@prometrika.com

Industry:

PROMETRIKA, LLC

Release Summary
Explore the ongoing experience with decentralized clinical trials (DCTs). Review data on DCT use and discuss what's most suited for support.
Release Versions
English

Contacts

For further information please contact
Kathy Zheng
kzheng@prometrika.com

Social Media Profiles
Facebook Page
LinkedIn Page
Twitter Page
More News From PROMETRIKA, LLC

PROMETRIKA Achieves Accreditation in Medidata Rave RTSM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--PROMETRIKA, LLC, is proud to announce it has recently achieved accreditation on Medidata Rave RTSM. Rave RTSM ties subject randomization and management of study drug/supplies directly into the study’s Rave EDC system. This integration streamlines data entry, reduces redundant data entry as compared against separate systems, and allows for mid-stream changes with minimal disruption should study design change. PROMETRIKA’s President and CEO, Miganush Stepanians,...

PROMETRIKA Announces Expanded Strategic Regulatory Consulting Services

CAMBRIDGE, Mass.--(BUSINESS WIRE)--PROMETRIKA, LLC has announced that it has expanded its strategic regulatory consulting services under the leadership of Aileen Ryan, MS, Senior Regulatory Advisor, who has been providing regulatory consulting services to PROMETRIKA’s client companies on a part-time basis for the past 2 years has now joined the company on a full-time basis. Ms. Ryan brings to this position over 40 years of diverse experience in pharmaceutical regulatory affairs, including regul...

Barry Mirrer, Head of Quality Assurance, PROMETRIKA Has Earned CIPP/E Certification

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Barry Mirrer, Head of Quality Assurance, PROMETRIKA, has earned the ANSI-accredited Certified Information Privacy Professional/Europe (CIPP/E) credential through the International Association of Privacy Professionals (IAPP). Mr. Mirrer has been involved with addressing privacy concerns, particularly those related to clinical trials and patient privacy, and providing privacy and security training to organizations for over 15 years. Besides his Quality Assurance...
Back to Newsroom